Related Topics News -

     
 Title only   |   Print 
     
翰森製藥新藥HS-10582片獲批開展臨床試驗

2026-08-06T  
翰森製藥治療骨肉瘤III期HS-20093臨床達主要終點

2026-07-29T  
《大行》野村料翰森製藥中期盈利受研發開支拖累 降目標價至37.24元

2026-07-27T  
《大行》里昂升翰森製藥目標價至42元 料明年多種新藥上市可支持盈利增長

2026-07-27T  
翰森製藥:Avere合併入NextCure 料將持有合併後實體多於30%股本

2026-07-14T  
翰森製藥HS-20093治療小細胞肺癌III期臨床達主要終點

2026-07-13T  
*港股漲逾460點重上24,400關 醫藥股炒高 長和漲半成 Minimax抽水逾160億挫9%

2026-07-10T  
恆指公司:恆生生物科技指數自6月低位反彈逾17% 成分股加大回購力度

2026-07-10T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.